s6y

CASI Pharmaceuticals, Inc.

Ticker
CASIF
CIK
1962738
Industry
Pharmaceutical Preparations
Formerly
CASI Pharmaceuticals Holdings, Inc.

Financials 1

  1. NT 20-F Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F for period ending Dec 31, 2025

Ownership 21

  1. 3 Initial statement of beneficial ownership of securities
  2. 3 Initial statement of beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 3 Initial statement of beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. 3 Initial statement of beneficial ownership of securities
  9. 3 Initial statement of beneficial ownership of securities
  10. 3 Initial statement of beneficial ownership of securities

All 21 ownership filings

Prospectus 11

  1. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  2. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. S-8 POS Post-effective amendment to a S-8 registration statement
  6. S-8 POS Post-effective amendment to a S-8 registration statement
  7. S-8 POS Post-effective amendment to a S-8 registration statement
  8. S-8 POS Post-effective amendment to a S-8 registration statement
  9. S-8 POS Post-effective amendment to a S-8 registration statement
  10. S-8 POS Post-effective amendment to a S-8 registration statement

All 11 prospectus filings

Other 124

  1. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. SCHEDULE 13D/A
  9. 20-F Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
  10. D Exempt (Private) Offering

All 124 other filings